tradingkey.logo

Organon Provides Update On Phase 2 Elena Proof-Of-Concept Study Evaluating OG-6219 In Patients With Endometriosis-Related Pain

ReutersJul 2, 2025 11:37 AM

- Organon & Co OGN.N:

  • ORGANON PROVIDES UPDATE ON PHASE 2 ELENA PROOF-OF-CONCEPT STUDY EVALUATING OG-6219 IN PATIENTS WITH ENDOMETRIOSIS-RELATED PAIN

  • ORGANON & CO - PHASE 2 STUDY ON OG-6219 DID NOT MEET PRIMARY ENDPOINT

  • ORGANON & CO - TO DISCONTINUE OG-6219 CLINICAL DEVELOPMENT PROGRAM

  • ORGANON & CO - OG-6219 DID NOT IMPROVE ENDOMETRIOSIS-RELATED PAIN COMPARED TO PLACEBO

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI